Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
French biotech Sensorion has filed its first regulatory application to start human testing of OTOF-GT, a gene therapy for one of the most common forms of congenital deafness. The therapy is ...
While OTOF-related deafness is very uncommon, accounting for around 8% of all congenital deafness, which is equivalent to around 20,000 people in Europe and the US combined, Regeneron said the ...
Hearing loss can be present at birth (congenital) or become evident later in life (acquired deafness). The distinction between acquired and congenital deafness specifies only the time that the ...
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
A new Georgia law is in effect that makes it mandatory for early testing for hearing loss, and pediatric Dr. Paula Harmon visited Good Day to discuss what parents need to know with Alex Whittler.